A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial. [electronic resource]
Producer: 20121017Description: 35-41 p. digitalISSN:- 1879-0518
- Adult
- Androstenes -- adverse effects
- Contraceptives, Oral, Combined -- adverse effects
- Endothelium, Vascular -- drug effects
- Estrogens -- adverse effects
- Ethinyl Estradiol -- adverse effects
- Female
- Hemodynamics -- drug effects
- Humans
- Mineralocorticoid Receptor Antagonists -- adverse effects
- Prospective Studies
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.